A suo motu study on drug pricing by the Ministry of Corporate Affairs has revealed exorbitant profit margins on 21 common drugs manufactured by Indian companies.
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/500-profit-margins-drugs-study-0
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/indian-express-new-delhi
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/planning-commission
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/ranbaxy-pharmaceuticals
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/ministry-health-and-family-welfare
